D. E. Shaw & Co., Inc. Teva Pharmaceutical Industries LTD Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 3,654,458 shares of TEVA stock, worth $80.7 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

3,654,458

Holding current value

$80.7 Million

% of portfolio

0.06%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$15.81 - $18.96 $35.3 Million - $42.3 Million	-2,230,589 Reduced 37.9%	3,654,458 $65.9 Million
Q2 2024 Aug 14, 2024	BUY	$12.78 - $17.4 $50.7 Million - $69 Million	3,966,146 Added 206.69%	5,885,047 $95.6 Million
Q1 2024 May 15, 2024	BUY	$10.67 - $14.43 $4.31 Million - $5.83 Million	404,319 Added 26.7%	1,918,901 $27.1 Million
Q4 2023 Feb 14, 2024	SELL	$8.12 - $10.63 $36.7 Million - $48.1 Million	-4,524,093 Reduced 74.92%	1,514,582 $15.8 Million
Q3 2023 Nov 14, 2023	BUY	$7.48 - $10.7 $4.36 Million - $6.24 Million	582,945 Added 10.69%	6,038,675 $61.6 Million
Q2 2023 Aug 14, 2023	BUY	$7.2 - $9.47 $29.1 Million - $38.3 Million	4,039,979 Added 285.36%	5,455,730 $41.1 Million
Q1 2023 May 15, 2023	SELL	$8.36 - $11.37 $6.72 Million - $9.14 Million	-803,544 Reduced 36.21%	1,415,751 $12.5 Million
Q4 2022 Feb 14, 2023	SELL	$7.95 - $9.48 $13.7 Million - $16.4 Million	-1,725,040 Reduced 43.73%	2,219,295 $20.2 Million
Q3 2022 Nov 14, 2022	BUY	$6.86 - $11.95 $18.1 Million - $31.5 Million	2,631,829 Added 200.52%	3,944,335 $31.8 Million
Q2 2022 Aug 15, 2022	SELL	$7.38 - $10.4 $17.1 Million - $24.1 Million	-2,314,089 Reduced 63.81%	1,312,506 $9.87 Million
Q1 2022 May 16, 2022	BUY	$7.33 - $9.39 $10.7 Million - $13.7 Million	1,455,442 Added 67.04%	3,626,595 $34.1 Million
Q4 2021 Feb 14, 2022	SELL	$7.9 - $10.19 $4.17 Million - $5.38 Million	-527,500 Reduced 19.55%	2,171,153 $17.4 Million
Q3 2021 Nov 15, 2021	BUY	$8.38 - $10.18 $21.8 Million - $26.4 Million	2,595,704 Added 2521.35%	2,698,653 $26.3 Million
Q2 2021 Aug 16, 2021	BUY	$9.9 - $11.56 $278,744 - $325,483	28,156 Added 37.65%	102,949 $1.02 Million
Q1 2021 May 17, 2021	SELL	$10.34 - $12.81 $6.29 Million - $7.8 Million	-608,800 Reduced 89.06%	74,793 $863,000
Q4 2020 Feb 16, 2021	BUY	$8.61 - $11.04 $3.2 Million - $4.1 Million	371,640 Added 119.13%	683,593 $6.6 Million
Q3 2020 Nov 16, 2020	BUY	$8.57 - $12.69 $1.27 Million - $1.88 Million	148,339 Added 90.66%	311,953 $2.81 Million
Q2 2020 Aug 14, 2020	SELL	$8.12 - $13.12 $2.01 Million - $3.25 Million	-248,018 Reduced 60.25%	163,614 $2.02 Million
Q1 2020 May 15, 2020	BUY	$6.69 - $13.45 $79,370 - $159,570	11,864 Added 2.97%	411,632 $3.7 Million
Q4 2019 Feb 14, 2020	SELL	$6.53 - $10.72 $13.6 Million - $22.3 Million	-2,080,991 Reduced 83.89%	399,768 $3.92 Million
Q3 2019 Nov 14, 2019	SELL	$6.16 - $9.6 $2.44 Million - $3.81 Million	-396,778 Reduced 13.79%	2,480,759 $17.1 Million
Q2 2019 Aug 14, 2019	BUY	$8.12 - $15.72 $21.7 Million - $42 Million	2,671,960 Added 1299.74%	2,877,537 $26.6 Million
Q1 2019 May 15, 2019	SELL	$15.58 - $20.01 $6.87 Million - $8.82 Million	-440,775 Reduced 68.19%	205,577 $3.22 Million
Q4 2018 Feb 14, 2019	BUY	$14.59 - $23.84 $3.9 Million - $6.38 Million	267,623 Added 70.66%	646,352 $9.97 Million
Q3 2018 Nov 14, 2018	BUY	$21.06 - $25.65 $2.52 Million - $3.07 Million	119,592 Added 46.15%	378,729 $8.16 Million
Q2 2018 Aug 14, 2018	SELL	$16.77 - $24.71 $16.9 Million - $24.9 Million	-1,005,699 Reduced 79.51%	259,137 $6.3 Million
Q1 2018 May 15, 2018	SELL	$16.68 - $22.07 $3.56 Million - $4.7 Million	-213,136 Reduced 14.42%	1,264,836 $21.6 Million
Q4 2017 Feb 14, 2018	SELL	$11.23 - $19.1 $331,666 - $564,099	-29,534 Reduced 1.96%	1,477,972 $28 Million
Q3 2017 Nov 14, 2017	BUY	$15.41 - $32.17 $23.2 Million - $48.5 Million	1,507,506	1,507,506 $26.5 Million

Others Institutions Holding TEVA

# of Institutions

625

Shares Held

573M

Call Options Held

19.6M

Put Options Held

6.77M

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $24.5B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account